Related Experiment Videos
Skin prick test reactivity to recombinant latex allergens
International Archives of Allergy and Immunology
|June 1, 2000
Summary
Recombinant latex allergens show clinical reactivity in skin prick tests for diagnosing latex allergy. A combination of Hev b 5, 6, and 7 allergens achieved 93% sensitivity and 100% specificity.
Area of Science:
- Immunology
- Allergology
- Biotechnology
Background:
- Latex allergy is a growing health concern, especially for healthcare workers.
- Current diagnostic methods for latex allergy include in vitro tests and skin prick tests (SPT) using natural rubber latex (NRL).
- Ten latex allergens (Hev b 1-10) have been identified, with most cloned as recombinant proteins for research.
Purpose of the Study:
- To compare the SPT reactivity of six recombinant latex allergens.
- To assess the diagnostic potential of these recombinant allergens against natural rubber latex proteins.
Main Methods:
- Six recombinant latex allergens were expressed and tested via skin prick testing in 31 latex-allergic individuals.
- Serial dilutions of recombinant allergens were used to determine reactivity levels.
- Latex-specific IgE levels were measured using the AlaSTAT assay.
Main Results:
- All six recombinant allergens demonstrated SPT reactivity in latex-allergic patients but not in controls.
- The frequency of sensitization to recombinant allergens mirrored previous findings with native NRL proteins.
- A combination of Hev b 5, 6, and 7 recombinant allergens diagnosed latex allergy with 93% sensitivity and 100% specificity.
Conclusions:
- Recombinant latex allergens are clinically reactive and suitable for diagnostic use.
- These allergens can be produced in a standardized manner.
- Recombinant allergens offer a potentially safe, sensitive, and specific approach for diagnosing latex allergy.